Bharat Biotech signed an agreement with Brazil to provide its COVID-19 vaccine Covaxin
The supplies of Covaxin are going to be prioritized for public market, through direct procurement by Brazil government, the corporate said during a statement.
Bharat Biotech on Tuesday, 12 January, signed an agreement with Precisa Medicamentos
According to a
Covaxin is being indigenously developed byBharatBiotechin collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).Meanwhile, on 3 January, India's drugs regulator had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use